• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The biology of incipient, pre-invasive or intraepithelial neoplasia.早期、侵袭前或上皮内肿瘤的生物学。
Cancer Biomark. 2010;9(1-6):21-39. doi: 10.3233/CBM-2011-0172.
2
Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?子宫颈脱落细胞中的遗传损伤。吸烟与恶性转化进展之间的关联及相互作用?
Acta Cytol. 1998 May-Jun;42(3):639-49. doi: 10.1159/000331820.
3
[High-grade prostatic intraepithelial neoplasia: the only accepted prostate cancer precursor lesion].[高级别前列腺上皮内瘤变:唯一被认可的前列腺癌前驱病变]
Pathologe. 2011 Nov;32 Suppl 2:237-41. doi: 10.1007/s00292-011-1500-9.
4
Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix.Maspin在子宫颈CIN 3、微浸润性鳞状细胞癌和浸润性鳞状细胞癌中的表达。
Mod Pathol. 2005 Aug;18(8):1102-6. doi: 10.1038/modpathol.3800393.
5
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients.前列腺炎症、增生性炎症萎缩和低级别前列腺上皮内瘤之间的地形和定量关系:前列腺炎患者的活检研究。
Int J Oncol. 2012 Dec;41(6):1950-8. doi: 10.3892/ijo.2012.1646. Epub 2012 Oct 1.
6
Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.人端粒酶逆转录酶在外阴上皮内瘤变和鳞状细胞癌中的表达:与生存素和 p53 的免疫组织化学研究。
Arch Pathol Lab Med. 2012 Nov;136(11):1359-65. doi: 10.5858/arpa.2011-0440-OA.
7
The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.p16 和半乳糖凝集素-3 在宫颈上皮内瘤变(CIN)和子宫颈鳞状细胞癌(SCC)中的表达。
J Obstet Gynaecol. 2021 Jul;41(5):785-790. doi: 10.1080/01443615.2020.1803235. Epub 2020 Oct 19.
8
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.免疫抑制但无 HIV 感染女性的宫颈癌筛查指南。
J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468.
9
The terminology of pre-invasive cervical lesions in the UK cervical screening programme.英国宫颈筛查项目中宫颈浸润前病变的术语
Cytopathology. 2015 Dec;26(6):346-50. doi: 10.1111/cyt.12307.
10
Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.靛胭脂辅助高倍放大染色结肠镜检查在溃疡性结肠炎上皮内瘤变检测及特征描述中的应用:一项前瞻性评估
Endoscopy. 2005 Dec;37(12):1186-92. doi: 10.1055/s-2005-921032.

引用本文的文献

1
Radiofrequency Ablation as an Alternative and Novel Procedure in the Intraepithelial Neoplasia Management: A Systematic Scoping Review.射频消融作为上皮内瘤变管理中的一种替代且新颖的方法:一项系统综述。
Health Sci Rep. 2025 Jun 23;8(6):e70938. doi: 10.1002/hsr2.70938. eCollection 2025 Jun.
2
A panel of biomarkers for skin squamous cell carcinoma: various functional entities and differential responses to resveratrol.一组用于皮肤鳞状细胞癌的生物标志物:多种功能实体及对白藜芦醇的不同反应。
Int J Clin Exp Pathol. 2019 Apr 1;12(4):1363-1377. eCollection 2019.
3
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.间充质干细胞分泌组:迈向再生医学中的无细胞治疗策略
Int J Mol Sci. 2017 Aug 25;18(9):1852. doi: 10.3390/ijms18091852.
4
Risk Stratification System for Oral Cancer Screening.口腔癌筛查风险分层系统。
Cancer Prev Res (Phila). 2016 Jun;9(6):445-55. doi: 10.1158/1940-6207.CAPR-15-0200. Epub 2016 Mar 28.
5
Polyomavirus BK and prostate cancer: an unworthy scientific effort?多瘤病毒BK与前列腺癌:一项无价值的科学研究?
Oncoscience. 2014 Apr 30;1(4):296-303. doi: 10.18632/oncoscience.32. eCollection 2014.
6
Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.与脂肪组织干细胞相比,人子宫颈干细胞分泌组对癌细胞和基质细胞的潜在治疗作用。
Oncotarget. 2014 Nov 15;5(21):10692-708. doi: 10.18632/oncotarget.2530.
7
Use of human specimens in research: the evolving United States regulatory, policy, and scientific landscape.人类标本在研究中的使用:不断演变的美国监管、政策及科学态势。
Diagn Histopathol (Oxf). 2013 Sep;19(9):322-330. doi: 10.1016/j.mpdhp.2013.06.015.
8
Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.导管原位癌和乳腺癌发生的分子流行病学研究机遇:跨学科方法
Breast Dis. 2014;34(3):105-16. doi: 10.3233/BD-130359.
9
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer.新辅助化疗后醛脱氢酶的表达与缺氧诱导因子 1 和 2α的表达相关,并可预测局部晚期乳腺癌的预后。
Clinics (Sao Paulo). 2013 May;68(5):592-8. doi: 10.6061/clinics/2013(05)03.
10
A quantitative diagnostic method for oral mucous precancerosis by Rose Bengal fluorescence spectroscopy.利用孟加拉玫瑰红荧光光谱定量诊断口腔黏膜癌前病变的方法。
Lasers Med Sci. 2013 Jan;28(1):241-6. doi: 10.1007/s10103-012-1054-y. Epub 2012 May 31.

本文引用的文献

1
Biologic characteristics of premalignant breast disease.癌前乳腺疾病的生物学特性。
Cancer Biomark. 2010;9(1-6):177-92. doi: 10.3233/CBM-2011-0187.
2
Biomarkers and the genetics of early neoplastic lesions.生物标志物与早期肿瘤病变的遗传学。
Cancer Biomark. 2010;9(1-6):41-64. doi: 10.3233/CBM-2011-0204.
3
the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.在分析之前对表面增强激光解吸电离/基质辅助激光解吸电离质谱数据进行审查和理解的必要性。
Cancer Inform. 2005;1(1):86-97.
4
Induction of myeloid-derived suppressor cells by tumor exosomes.肿瘤外泌体诱导髓源性抑制细胞
Int J Cancer. 2009 Jun 1;124(11):2621-33. doi: 10.1002/ijc.24249.
5
Myeloid-derived suppressor cells as regulators of the immune system.髓源性抑制细胞作为免疫系统的调节因子。
Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506.
6
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.乳腺癌细胞系包含具有转移能力和独特分子特征的功能性癌症干细胞。
Cancer Res. 2009 Feb 15;69(4):1302-13. doi: 10.1158/0008-5472.CAN-08-2741. Epub 2009 Feb 3.
7
Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.Tgfbr1单倍体不足是结直肠癌发生的一个有力修饰因子。
Cancer Res. 2009 Jan 15;69(2):678-86. doi: 10.1158/0008-5472.CAN-08-3980.
8
Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications.癌症干细胞、自我播种与递减指数生长:理论与临床意义
Breast Dis. 2008;29:27-36. doi: 10.3233/bd-2008-29104.
9
Thymus exosomes-like particles induce regulatory T cells.胸腺外泌体样颗粒诱导调节性T细胞。
J Immunol. 2008 Oct 15;181(8):5242-8. doi: 10.4049/jimmunol.181.8.5242.
10
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.脂联素(ADIPOQ)基因和脂联素受体1(ADIPOR1)基因的变异与结直肠癌风险
JAMA. 2008 Oct 1;300(13):1523-31. doi: 10.1001/jama.300.13.1523.

早期、侵袭前或上皮内肿瘤的生物学。

The biology of incipient, pre-invasive or intraepithelial neoplasia.

机构信息

Department of Pathology, Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Cancer Biomark. 2010;9(1-6):21-39. doi: 10.3233/CBM-2011-0172.

DOI:10.3233/CBM-2011-0172
PMID:22112468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3430522/
Abstract

Invasive tumors (cancers or malignant lesions) typically develop in the setting in which there is the presence of putative non-invasive lesions and the development of these non-invasive lesions frequently precedes the development of cancers. For some organs, such as the oral cavity, cervix and skin, the respective putative pre-invasive lesions can be observed over time and documented to progress to invasive lesions. However, for less readily observable lesions, such as those of the prostate, the progression of the pre-invasive lesions, e.g., prostatic intraepithelial neoplasia (PIN) and prostatic proliferative inflammatory atrophy (PIA) to prostatic cancer are more difficult to document. Thus, for most organ systems, specific pre-invasive neoplastic lesions have been proposed based upon the apparent observations of one or more of the following: 1) microinvasive disease developing from a pre-invasive neoplastic lesion, 2) the general association of the pre-invasive lesion with invasive lesions, 3) the subsequent development of invasive lesions following diagnosis of the pre-invasive lesion, 4) correlations of the molecular features of the putative pre-invasive lesion with the matching invasive lesions, and 5) reductions in the rate of cancer following removal of the pre-invasive lesion. When there are mixtures of pre-invasive lesions with actual cancers in the same case, some of the above specific associations are more difficult to make. Several terms have been used to describe pre-invasive lesions, many of which are now less useful as our knowledge of these lesions increases. It is now commonly accepted that these lesions are a features of the spectrum of neoplastic development and most are accepted as ``neoplastic lesions'' with associated molecular features, even though they may be reversible even if they have mutations in suppressor genes (e.g., p53) or are associated with viral etiologies (e.g., cervical intraepithelial neoplasia). The overall term, "pre-invasive neoplasia", seems to best describe these putative pre-invasive lesions. Thus, terms such as incipient neoplasia should be abandoned. The term "intra-epithelial neoplasia" with an associated grade, which has been developed for pre-invasive neoplastic lesions of the cervix, i.e. cervical intraepithelial neoplasia (CIN), seems to be a terminology that adds consistency across epithelial organs. Thus, adoption of these terms for the additional organ sites of pancreas (PanIN) and prostate (PIN) seems accepted. Less descriptive terms such as the degrees of dysplasia of the oral cavity and bronchopulmonary system and actinic keratosis and Bowen's disease of the skin might be better designated as oral intraepithelial neoplasia (OIN), pulmonary intraepithelial neoplasia (PulIN) and dermal intraepithelial neoplasia (DIN). The etiology of pre-invasive neoplasia is the etiology of the matching cancers. Some obvious initiating factors include exposure to the whole range of ionizing and non-ionizing radiation, tobacco abuse and a broad range of other carcinogens (e.g., benzene). A frequent initiation factor is the setting of long standing continuing damage, inflammation and repair (LOCDIR) which leads to early molecular features associated with neoplasia after about one year. An excellent example of this is ulcerative colitis (UC) in which dysregulation of microsatellite repair enzymes have been documented one year following diagnosis of UC. While the nomenclature, description, diagnosis and etiology of pre-invasive neoplasia has advanced, approaches to therapy of such lesions have not progressed adequately even though it has been identified that, for example, removal of polyps periodically from the colorectum, DCIS from the breast, and high grade CIN from the cervix, results in a reduction in the development of cancers of the colorectum, breast, and cervix, respectively. With the development of more molecularly targeted therapy with fewer side effects, preventive therapies may be more successfully targeted to pre-invasive neoplastic lesions.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/21d7641e5b83/nihms-402045-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/bef165e35271/nihms-402045-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/bf99ef057eb5/nihms-402045-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/087970e4e671/nihms-402045-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/e2b0d9aa202f/nihms-402045-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/eaca8d304311/nihms-402045-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/564eba6e648b/nihms-402045-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/db0f19efb5a3/nihms-402045-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/c02e83094abf/nihms-402045-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/e5e4cd2c89e3/nihms-402045-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/21d7641e5b83/nihms-402045-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/bef165e35271/nihms-402045-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/bf99ef057eb5/nihms-402045-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/087970e4e671/nihms-402045-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/e2b0d9aa202f/nihms-402045-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/eaca8d304311/nihms-402045-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/564eba6e648b/nihms-402045-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/db0f19efb5a3/nihms-402045-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/c02e83094abf/nihms-402045-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/e5e4cd2c89e3/nihms-402045-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff99/3430522/21d7641e5b83/nihms-402045-f0010.jpg
摘要

侵袭性肿瘤(癌症或恶性病变)通常在存在疑似非侵袭性病变的情况下发展,而这些非侵袭性病变的发展通常先于癌症的发生。对于某些器官,如口腔、宫颈和皮肤,相应的疑似前病变可以随着时间的推移被观察到,并记录为进展为侵袭性病变。然而,对于较难观察到的病变,如前列腺,前病变(如前列腺上皮内瘤变(PIN)和前列腺增生性炎症萎缩(PIA))向前列腺癌的进展更难记录。因此,对于大多数器官系统,基于以下一种或多种明显观察结果,提出了特定的前肿瘤性病变:1)从前肿瘤性病变发展而来的微侵袭性疾病,2)前病变与侵袭性病变的一般关联,3)在前病变诊断后侵袭性病变的后续发展,4)推测前病变的分子特征与匹配的侵袭性病变的相关性,以及 5)在前病变切除后癌症发生率的降低。当同一病例中既有前病变又有实际癌症时,上述某些特定关联就更难做出。已经使用了几个术语来描述前病变,随着我们对这些病变认识的提高,其中许多术语现在已经不太有用了。现在普遍认为,这些病变是肿瘤发展谱的一个特征,大多数病变被认为是具有相关分子特征的“肿瘤性病变”,即使它们可能具有抑癌基因(如 p53)的突变,或者与病毒病因(如宫颈上皮内瘤变)有关。总的来说,“前肿瘤性病变”这个术语似乎最能描述这些疑似前肿瘤性病变。因此,“初发肿瘤”等术语应该被废弃。术语“上皮内肿瘤”及其相关分级,已经为宫颈前肿瘤性病变(即宫颈上皮内瘤变(CIN))所开发,似乎是一种在整个上皮器官中增加一致性的术语。因此,似乎已经接受了将这些术语用于胰腺(PanIN)和前列腺(PIN)等其他器官部位。口腔和支气管肺系统的异型增生程度以及皮肤的光化性角化病和 Bowen 病等不太具描述性的术语可能更好地指定为口腔上皮内肿瘤(OIN)、肺上皮内肿瘤(PulIN)和皮肤上皮内肿瘤(DIN)。前肿瘤性病变的病因也是相应癌症的病因。一些明显的起始因素包括接触各种电离和非电离辐射、滥用烟草以及广泛的其他致癌物质(如苯)。一个常见的起始因素是长期持续损伤、炎症和修复(LOCDIR),它会导致大约一年后与肿瘤发生相关的早期分子特征。溃疡性结肠炎(UC)就是一个很好的例子,在 UC 诊断后一年,已经记录到微卫星修复酶的失调。虽然前肿瘤性病变的命名法、描述、诊断和病因学已经取得了进展,但这些病变的治疗方法并没有得到充分的发展,尽管已经确定,例如,定期从结肠直肠切除息肉、从乳房切除 DCIS(导管原位癌),以及从宫颈切除高级别 CIN,分别会降低结直肠、乳房和宫颈癌症的发生。随着更具分子靶向性和更少副作用的治疗方法的发展,预防性治疗可能更有针对性地针对前肿瘤性病变。